ALBANY MOLECULAR RESEARCH INC.

MA

Pharmaceuticals

Active 2016–2018.

Filings

9

Filed By

1

Reported In-House

—

Reported By Firms

$190,000

Filings

All 2018 2017 2016

Year	Firm	Period	Amount	Doc
2018	RUBICON ADVISORS, LLC	3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination	$10,000
2018	RUBICON ADVISORS, LLC	2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report	$30,000
2018	RUBICON ADVISORS, LLC	1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report	$30,000
2017	RUBICON ADVISORS, LLC	4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report	$30,000
2017	RUBICON ADVISORS, LLC	3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report	$30,000
2017	RUBICON ADVISORS, LLC	2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report	$30,000
2017	RUBICON ADVISORS, LLC	1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report	$30,000
2017	RUBICON ADVISORS, LLC	1st Quarter (Jan 1 - Mar 31) AMENDED	—
2016	RUBICON ADVISORS, LLC	1st Quarter (Jan 1 - Mar 31) Registration	—

Filed By

Firm	Filings	Amount
RUBICON ADVISORS, LLC	9	$190,000

Issue Areas

Issue	Activities
Pharmacy	8
Health Issues	1